Hyaluronic Acid-based Dermal Fillers Market Demand, Size, Report to 2032
The global hyaluronic acid-based dermal fillers market size was exhibited at USD 4.85 billion in 2022 and is projected to hit around USD 10.58 billion by 2032, growing at a CAGR of 8.11% during the forecast period 2023 to 2032.
Key Pointers:
Hyaluronic Acid-based Dermal Fillers Market Report Scope
| Report Coverage | Details |
| Market Size in 2023 | USD 5.24 Billion |
| Market Size by 2032 | USD 10.58 Billion |
| Growth Rate From 2023 to 2032 | CAGR of 8.11% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | Product, Application |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional Scope | North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa |
| Key Companies Profiled | AbbVie; Galderma Laboratories, L.P.; Merz Pharmaceuticals , Genzyme Corporation, Anika Therapeutics Inc., LG Life Sciences, LTD (LG Chem), Bio plus Co. Ltd., Sculpt Luxury, Dermal Fillers Ltd;, Bioxis Pharmaceutical; Sinclair Pharma; Laboratories, Vivacy; Bohus Biotech AB |
The primary factor driving the growth of the market are the growing demand for non-invasive aesthetic procedures and increasing awareness regarding the application of Hyaluronic Acid (HA) in beauty segment. In addition, increased investment in R&D for novel advanced innovations in dermal products is propelling the market's growth. The trend of aesthetic procedures is growing among men. More men are concerned regarding the negative impact of aging on their appearance & facial features; this is increasing the demand for facial dermal fillers. As per the ISPAS global survey, 12.2% population opting for non-surgical procedures involving HA based fillers, accounted for men.
The advent of technology is shaping the aesthetic market. In 2021, laser resurfacing treatment was introduced in the market having higher efficiency in addressing various skin concerns. The technology applies laser for solving all the dermal issues at once. In addition, the new technology is lower-invasive in response to the demand for non-invasive techniques. Key players are dedicated to the development of advanced solutions to have a competitive edge in the hyaluronic acid market. The increasing number of new product approvals is propelling market opportunities. For instance, in January 2022, RHA Redensity, a novel dermal filler for reducing the wrinkles on skin, received U.S. FDA approval RHA Redensity is a gel implant produced from sodium hyaluronic acid which is injected into particular locations of the facial tissue for smoothening out lines & wrinkles.
The initial phase of the pandemic negatively impacted the market. The governments & healthcare players had increased focus for supporting the diagnostics & treatment methods for COVID-19. The disruption in supply of products & equipment for aesthetic procedures & restrictions on the procedures drastically impacted the market. The later part of 2020 witnessed increasing demand for the market. According to the data by the International Society of Plastic Surgery (ISAP in 2020, the overall demand for nonsurgical procedures, hair removal treatment and primarily fillers increased. The demand is expected to be higher post COVID-19 due to rising importance of aesthetic appearance & growing preference for non-invasive procedure.
The stringent government guidelines & regulations in the U.S., Europe Union & international markets for the development, branding & production of HA-based products are restraining the market. These stringent laws enable that quality products are utilized by healthcare facilities, including doctors as well as other end users. For instance, according to an 2018 FDA report, Juvederm must only be available for sale as well as injected with a licensed healthcare provider's recommendation. The FDA has also recommended patients and their doctors to refrain from using Juvederm Ultra 2, 3, & 4 due to non-approval of the product by U.S. FDA. This is restricting the accessibility of latest products.
Some of the prominent players in the Hyaluronic Acid-based Dermal Fillers Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Hyaluronic Acid-based Dermal Fillers market.
By Product
By Application
By Region
Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Product
1.1.2 Application
1.1.3 Regional Scope
1.1.4 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Nova one advisor Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.2 Volume Price Analysis
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
1.9.3 Objective 3
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Product
2.2.2 Application
2.2.3 Region
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Market Segmentation
3.3 Penetration & Growth Prospect Mapping
3.4 Clinical Trials
3.5 User Perspective Analysis
3.5.1 Consumer Behavior Analysis
3.5.2 Market Influencer Analysis
3.6 Market Dynamics
3.6.1 Market Driver Analysis
3.6.1.1 Increasing Geriatric Population
3.6.1.2 Growing demand for anti-aging solutions and minimally invasive aesthetic treatment
3.6.1.3 Growing applications in regenerative medicine and tissue engineering
3.6.2 Market Restraint Analysis
3.6.2.1 High cost and side effects associated with hyaluronic acid cycles
3.6.2.2 Stringent regulations
3.7 Business Environment Analysis Tools
3.7.1 Porter’s five forces analysis
3.7.1.1 Bargaining power of buyers: Low
3.7.1.2 Bargaining power of suppliers: Moderate
3.7.1.3 Competitive rivalry: High
3.7.1.4 Threat of new entrants: Moderate
3.7.1.5 Threat of substitutes: Low
3.7.2 SWOT Analysis, by PESTEL
3.7.2.1 Political & legal
3.7.2.2 Economic
3.7.2.3 Technological
3.7.3 Clinical Trials
3.7.4 Major Deals & Strategic Alliances Analysis
3.7.4.1 Joint ventures
3.7.4.2 Mergers & acquisitions
3.7.5 Qualitative Analysis: Impact of COVID-19 on Hyaluronic Acid-based Dermal Fillers Market Market
Chapter 4 Hyaluronic Acid-based Dermal Fillers Market Market: Product Analysis
4.1 Hyaluronic Acid-based Dermal Fillers Market by Product Market Share Analysis, 2022 & 2032
4.2 Segment Dashboard
4.3 Global Hyaluronic Acid-based Dermal Fillers Market Market, by Product, 2020 - 2032
4.4 Market Size and Forecasts and Trend Analysis, 2020 - 2032 for the Product
4.4.1 Single Phase Products
4.4.1.1 Single Phase Products Market-2032
4.4.2 Duplex Products
4.4.2.1 Duplex Products based market, 2020 - 2032
Chapter 5Hyaluronic Acid-based Dermal Fillers Market Market: Application Analysis
5.1 Hyaluronic Acid-based Dermal Fillers Market Application Market Share Analysis, 2022 and 2032
5.2 Segment Dashboard
5.3 Market Size and Forecasts and Trend Analysis, 2020 - 2032 for the Following Application
5.3.1 Wirnkle Correction
5.3.1.1 Wrinkle correction market, 2020 - 2032
5.3.2 Lip Augmentation
5.3.2.1 Lip Augmentation Market, 2020 - 2032
5.3.3 Rhinoplasty
5.3.3.1 Rhinoplasty Market, 2020 - 2032
5.4. Rhinoplasty
5.4.1 Rhinoplasty Market, 2020 - 2032
Chapter 6 Regional Outlook
6.1 Regional market share analysis, 2022 & 2032
6.2 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
6.3 Market Size, & Forecasts and Trend Analysis, 2022 to 2032
6.3.1 North America
6.3.1.1 North America Hyaluronic Acid-based Dermal Fillers market, By Product 2020 - 2032 (USD Million
6.3.1.2 North America Hyaluronic Acid-based Dermal Fillers market, By Application 2020 - 2032 (USD Million
6.3.1.2 U.S.
6.3.1.2.1 U.S. Hyaluronic Acid-based Dermal Fillers Market By Product, 2020 - 2032
6.3.1.2.2 U.S. Hyaluronic Acid-based Dermal Fillers Market By Application , 2020 - 2032 (USD Million
6.3.1.3 Canada
6.3.1.3.1 Canada Hyaluronic Acid-based Dermal Fillers Market By Product, 2020 - 2032
6.3.1.3.2 Canada Hyaluronic Acid-based Dermal Fillers Market By Application, 2020 - 2032
6.3.2 Europe
6.3.2.1 Europe Hyaluronic Acid-based Dermal Fillers Market By Product, 2020 - 2032
6.3.2.2 Europe Hyaluronic Acid-based Dermal Fillers Market By Application, 2020 - 2032
6.3.2.3 U.K.
6.3.2.3.1 U.k. Hyaluronic Acid-based Dermal Fillers Market by Product, 2020 - 2032
6.3.2.3.2 U.k. Hyaluronic Acid-based Dermal Fillers Market by Application, 2020 - 2032
6.3.2.4 Germany
6.3.2.4.1 Germany Hyaluronic Acid-based Dermal Fillers by Product, 2020 - 2032
6.3.2.4.2 Germany Hyaluronic Acid-based Dermal Fillers Market by Application, 2020 - 2032
6.3.2.5 France
6.3.2.5.1 France Hyaluronic Acid-based Dermal Fillers Market by Product, 2020 - 2032
6.3.2.5.2 France Hyaluronic Acid-based Dermal Fillers Market by Application, 2020 - 2032
6.3.2.6 Italy
6.3.2.6.1 Italy Hyaluronic Acid-based Dermal Fillers Market By Product, 2020 - 2032
6.3.2.6.2 Italy Hyaluronic Acid-based Dermal Fillers Market By Application , 2020 - 2032
6.3.2.7 Spain
6.3.2.7.1 Spain Hyaluronic Acid-based Dermal Fillers Market by Product, 2020 - 2032
6.3.2.7.2 Spain Hyaluronic Acid-based Dermal Fillers Market by Application, 2020 - 2032
6.3.2.8 Sweden
6.3.2.8.1 Sweden Hyaluronic Acid-based Dermal Fillers Market by Product, 2020 - 2032
6.3.2.8.2 Sweden Hyaluronic Acid-based Dermal Fillers Market by Application, 2020 - 2032
6.3.2.9 Norway
6.3.2.9.1 Norway Hyaluronic Acid-based Dermal Fillers Market by Product , 2020 - 2032
6.3.2.9.2 Norway Hyaluronic Acid-based Dermal Fillers Market by Application , 2020 - 2032
6.3.2.10 Denmark
6.3.2.10.1 Denmark Hyaluronic Acid-based Dermal Fillers Market by Product, 2020 - 2032
6.3.2.10.2 Denmark Hyaluronic Acid-based Dermal Fillers Market by Application, 2020 - 2032
6.3.2.11 Rest of Europe
6.3.2.11.1 Rest of Europe Hyaluronic Acid-based Dermal Fillers Market by Product, 2020 - 2032
6.3.2.11.2 Rest of Europe Hyaluronic Acid-based Dermal Fillers Market by Application, 2020 - 2032
6.3.3 Asia Pacific
6.3.3.1 Asia Pacific Hyaluronic Acid-based Dermal Fillers Market by Product, 2020 - 2032
6.3.3.2 Asia Pacific Hyaluronic Acid-based Dermal Fillers Market by Application, 2020 - 2032
6.3.3.3 Japan
6.3.3.3.1 Japan Hyaluronic Acid-based Dermal Fillers Market by Product, 2020 - 2032
6.3.3.3.2 Japan Hyaluronic Acid-based Dermal Fillers Market by Application, 2020 - 2032
6.3.3.4 China
6.3.3.4.1 China Hyaluronic Acid-based Dermal Fillers Market by Product, 2020 - 2032
6.3.3.4.2 China Hyaluronic Acid-based Dermal Fillers Market by Application, 2020 - 2032
6.3.3.5 India
6.3.3.5.1 India Hyaluronic Acid-based Dermal Fillers Market by Product, 2020 - 2032
6.3.3.5.2 India Hyaluronic Acid-based Dermal Fillers Market by Application, 2020 - 2032
6.3.3.6 Australia
6.3.3.6.1 Australia Hyaluronic Acid-based Dermal Fillers Market by Product, 2020 - 2032
6.3.3.6.2 Australia Hyaluronic Acid-based Dermal Fillers Market by Application, 2020 - 2032
6.3.3.7 Thailand
6.3.3.7.1 Thailand Hyaluronic Acid-based Dermal Fillers Market by Product, 2020 - 2032
6.3.3.7.2 Thailand Hyaluronic Acid-based Dermal Fillers Market by Application, 2020 - 2032
6.3.3.8 South Korea
6.3.3.8.1 South Korea Hyaluronic Acid-based Dermal Fillers Market by Product, 2020 - 2032
6.3.3.8.2 South Korea hyaluonic Acid Based Fillers Market by Application, 2020 - 2032
6.3.3.9 Rest of Asia Pacific
6.3.3.9.1 Rest of Asia Pacific Hyaluronic Acid-based Dermal Fillers Market by Product, 2020 - 2032
6.3.3.9.2 Rest of Asia Pacific Hyaluonic Acid Based Fillers Market by Application, 2020 - 2032 (USD Million
6.3.4 Latin America
6.3.4.1 Latin America Hyaluronic Acid-based Dermal Fillers Market by Product , 2020 - 2032
6.3.4.2 Latin America Hyaluronic Acid-based Dermal Fillers Market by Application , 2020 - 2032
6.3.4.3 Brazil
6.3.4.3.1 Brazil Hyaluronic Acid-based Dermal Fillers Market by Product, 2020 - 2032
6.3.4.3.2 Brazil Hyaluronic Acid-based Dermal Fillers Market by Application, 2020 - 2032
6.3.4.4 Mexico
6.3.4.4.1 Mexico Hyaluronic Acid-based Dermal Fillers Market by Product , 2020 - 2032
6.3.4.4.2 Mexico Hyaluronic Acid-based Dermal Fillers Market by Application, 2020 - 2032
6.3.4.5 Argentina
6.3.4.5.1 Argentina Hyaluronic Acid-based Dermal Fillers Market by Product, 2020 - 2032
6.3.4.5.2 Argentina Hyaluronic Acid-based Dermal Fillers Market by Application, 2020 - 2032
6.3.4.6 Rest of LATAM
6.3.4.6.1 Rest of LATAM Hyaluronic Acid-based Dermal Fillers Market by Product, 2020 - 2032
6.3.4.6.2 Best of LATAM Hyaluronic Acid-based Dermal Fillers Market by Application, 2020 - 2032
6.3.5 Middle East & Africa
6.3.5.1 MEA Hyaluronic Acid-based Dermal Fillers Market by Product, 2020 - 2032
6.3.5.2 MEA Hyaluronic Acid-based Dermal Fillers Market by Application, 2020 - 2032
6.3.5.3 South Africa
6.3.5.3.1 South Africa Hyaluronic Acid-based Dermal Fillers Market by Product, 2020 - 2032
6.3.5.3.2 South Africa Hyaluronic Acid-based Dermal Fillers Market by Application, 2020 - 2032
6.3.5.4 Saudi Arabia
6.3.5.4.1 Saudi Arabia Hyaluronic Acid-based Dermal Fillers Market by Product, 2020 - 2032
6.3.5.4.3 Saudi Arabia Hyaluronic Acid-based Dermal Fillers Market by Application, 2020 - 2032
6.3.5.5 UAE
6.3.5.5.1 UAE Hyaluronic Acid-based Dermal Fillers Market by Product, 2020 - 2032
6.3.5.5.2 UAE Hyaluronic Acid-based Dermal Fillers Market by Application, 2020 - 2032
6.3.5.6 Kuwait
6.3.5.6.1 Kuwait Hyaluronic Acid-based Dermal Fillers Market by Product, 2020 - 2032
6.3.5.6.2 Kuwait Hyaluronic Acid-based Dermal Fillers Market by Application, 2020 - 2032
6.3.5.7 Rest of MEA
6.3.5.7.1 Rest of MEA Hyaluronic Acid-based Dermal Fillers Market by Product, 2020 - 2032
6.3.5.7.2 Rest of MEA Hyaluronic Acid-based Dermal Fillers Market by Application, 2020 - 2032
Chapter 7 Competitive Analysis
7.1 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
7.2 Vendor Landscape
7.2.1 Strategy Mapping
7.2.2 Launch of New Products
7.2.3 Merger and Acquisition
7.2.4 Product Approvals
7.2.5 Partnerships
7.2.6 Marketing & Promotions
7.3 Company Market Position Analysis
7.4 Company Profiles
7.4.1 Allergan
7.4.1.1 Company overview
7.4.1.2 Financial performance
7.4.1.3 Product benchmarking
7.4.1.4 Strategic initiatives
7.4.1.5 SWOT analysis
7.4.2 Galderma Laboratories L.P.
7.4.2.1 Company overview
7.4.2.2 Financial performance
7.4.2.3 Product benchmarking
7.4.2.4 Strategic initiatives
7.4.2.5 SWOT analysis
7.4.3 Merz Pharmaceuticals
7.4.3.1 Company overview
7.4.3.2 Financial performance
7.4.3.3 Product benchmarking
7.4.3.4 Strategic initiatives
7.4.3.5 SWOT analysis
7.4.4 Genzyme Corporation
7.4.4.1 Company overview
7.4.4.2 Financial performance
7.4.4.3 Product benchmarking
7.4.4.4 Strategic initiatives
7.4.4.5 SWOT analysis
7.4.5 Anika Therapeutics Inc
7.4.5.1 Company overview
7.4.5.2 Financial performance
7.4.5.3 Product benchmarking
7.4.5.4 Strategic initiatives
7.4.5.5 SWOT analysis
7.4.6 LG Life Sciences
7.4.6.1 Company overview
7.4.6.2 Financial performance
7.4.6.3 Product benchmarking
7.4.6.4 Strategic initiatives
7.4.6.5 SWOT analysis
7.4.7 Bio plus Co
7.4.7.1 Company overview
7.4.7.2 Financial performance
7.4.7.3 Product benchmarking
7.4.7.4 Strategic initiatives
7.4.7.5 SWOT analysis
7.4.8 Sculpt Luxury Dermal Fillers Ltd
7.4.8.1 Company overview
7.4.8.2 Financial performance
7.4.8.3 Product benchmarking
7.4.8.4 Strategic initiatives
7.4.8.5 SWOT analysis
7.4.9 Bioxis Pharmaceutical
7.4.9.1 Company overview
7.4.9.2 Financial performance
7.4.9.3 Product benchmarking
7.4.9.4 Strategic initiatives
7.4.10 Sinclair Pharma
7.4.10.1 Company overview
7.4.10.2 Financial Performance
7.4.10.3 Product benchmarking
7.4.10.4 Strategic initiatives
7.4.11 Laboratories Vivacy
7.4.11.1 Company overview
7.4.11.2 Financial performance
7.4.11.3 Services benchmarking
7.4.11.4 Strategic initiatives
7.4.12 Bohus Biotech AB
7.4.12.1 Company overview
7.4.12.2 Financial performance
7.4.12.3 Product benchmarking
7.4.12.4 Strategic initiatives
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers